Denmark Sweden Norway Finland

Human VEGF R2 (Luc) HEK293 Reporter Cell

Vascular endothelial growth factor (VEGF) is a potent angiogenic inducer that stimulates the expression of tissue factor (TF), the major cellular initiator of blood coagulation. VEGF could inhibit apoptosis and increase cellular proliferation. As the most abundant splice variant of VEGF-A, VEGF165 binds to the receptor tyrosine kinases, VEGFR1 and VEGFR2, leads to activation of the PI3K/AKT, p38 MAPK, FAK, and paxillin. Due to the angiogenesis ability of VEGF in cancer, interfering VEGF/VEGFR2 interaction has become an attractive method in cancer therapy.

Please sign in to see prices
Or contact us directly
Product #: CHEK-ATF044-2Vials-202 Unit size: 1Vial*2 Supplier: ACROBiosystems Available in the following countries:
Denmark Norway Sweden Finland
Got any questions?

Get in touch with one of our specialists

Henrik Tind Nielsen profile picture
Henrik Tind Nielsen CCO & Product Specialist Automation
Cristina Battagli profile picture
Cristina Battagli Product Specialist: Diagnostics, Metabolomics, Imaging & Cell Biology
News and Promotions
Kem-En-Tec Nordic A/S Logo
Kem-En-tec Nordic A/S
 Kuldyssen 10, 2630 Taastrup
 +45 3927 1777
 Parkvägen 12, 448 34 Floda
 +46 18 149000
 info@kem-en-tec-nordic.com
Follow Us
Sign up for our newsletter
Yes, I give permission to store my data